CN Stock MarketDetailed Quotes

002390 Guizhou Xinbang Pharmaceutical

Watchlist
  • 3.92
  • +0.07+1.82%
Market Closed Apr 29 15:00 CST
7.62BMarket Cap25.96P/E (TTM)

Guizhou Xinbang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guizhou Xinbang Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.58B

-1.41%
EPS(YoY)

0.03

0.00%
Analyst Rating

Strong Buy

Apr 29, 2024

Guizhou Xinbang Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2021/FY6.472B / 6.662B--
--2019/FY6.655B / 6.476B--
DatePeriodRevenue/EstimateEarnings Call
--2021/FY6.472B / 6.662B--
--2019/FY6.655B / 6.476B--

Guizhou Xinbang Pharmaceutical Earnings Reports

  • Guizhou Xinbang Pharmaceutical: 2024 First Quarter Report

    12:00 ET

  • Xinbang Pharmaceuticals: 2023 Annual Report

    Apr 15 12:00 ET

  • Xinbang Pharmaceuticals: 2023 Annual Report Summary

    Apr 15 12:00 ET

  • Xinbang Pharmaceutical: Report for the third quarter of 2023

    Oct 29, 2023 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 29, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg